Case Studies

Excellence in early and late phase clinical trials across an expansive range of therapeutic areas.

MAC brings together a diverse set of capabilities and research experience for the benefit of pharma, biotech and CROs. Our ability to recruit participants and conduct clinical trials with expertise across an extensive range of medical conditions sets us apart from other research organisations.

Alzheimers Disease
Alzheimers Disease

Timeline Recovery: MAC was approached 12 months into the trial and recruited a significant number of patients.

press to zoom
Anxiety
Anxiety
press to zoom
Atopic Dermatitis 1
Atopic Dermatitis 1

This study ran across 4 countries (UK, Germany, Belgium and Poland). MAC randomized 49% of the patients.

press to zoom
Atopic Dermatitis 2
Atopic Dermatitis 2
press to zoom
Bulimia
Bulimia
press to zoom
Depression
Depression

MAC recruited more patients in this depression study than several larger countries.

press to zoom
Diabetes
Diabetes
press to zoom
Diarrhoea
Diarrhoea
press to zoom
Fibromyalgia
Fibromyalgia

In this study MAC randomised 67% of the total UK study population.

press to zoom
MCI
MCI

Timeline Recovery: The IMP was going out of date. MAC successfully delivered within timeframe (single site).

press to zoom
Multiple Sclerosis
Multiple Sclerosis
press to zoom
Osteoarthritis
Osteoarthritis
press to zoom
Peripheral Neuropathic Pain
Peripheral Neuropathic Pain

This complex in-patient clinical trial ran in 4 countries, but many sites did not recruit any patients.

press to zoom
Post Menopause Hot Flushes
Post Menopause Hot Flushes
press to zoom
Psoriasis
Psoriasis
press to zoom
Sleep
Sleep
press to zoom

MAC EnVision® patient engagement solutions provide access to an extensive range of therapeutic areas.